Obesity News

PHILADELPHIA — In this Healio video exclusive, Neha J. Pagidipati, MD, MPH, highlights growing evidence on the relationship between weight change and risk for cardiovascular disease.

Patients who were prescribed phentermine after losing fewer than 20 pounds while on a GLP-1 receptor agonist were more likely to lose weight 1 year after GLP-1 discontinuation than those who were not prescribed phentermine, recent findings show.

PHILADELPHIA — Older adults with end-stage kidney disease undergoing bariatric surgery may be more likely to achieve kidney transplant, according to data presented at the American Transplant Congress.

Multidisciplinary experts from across cardiometabolic subspecialties will gather again to showcase the latest clinical research at the Heart in Diabetes CME Conference.

Due to demographic changes and a rise in risk factors, the prevalence and economic burden of heart disease and stroke in the United States are expected to increase dramatically by 2050, according to the American Heart Association.

The net benefit of GLP-1 receptor agonists in adults with overweight or obesity who do not have diabetes depends on their weight loss target and willingness to accept harms, according to researchers.

CHICAGO — Glucagon-like peptide-1 receptor agonists lowered the risk for obesity-related cancers compared with bariatric surgery among individuals with a BMI of at least 35, according to data presented at ASCO Annual Meeting.

BOSTON — Breast cancer survivors are more likely to have weight gain of 10% or more during follow-up compared with healthy controls, with the strongest predictors younger age at diagnosis and lower weight at baseline, data show.

BOSTON — Younger adults are at greater cardiovascular disease risk if they have obesity for 10 years, but a single excess weight measurement does not predict risk for heart-related events over time, according to data presented at ENDO 2024.

BOSTON — In a proof-of-concept study, women with obesity who took semaglutide reported enhanced taste perception, and researchers observed altered gene expression in their tongues and their brain reward response related to sweet tastes.